Loading candles…
TAKE Solutions Ltd was incorporated in 2000 and operates primarily in the Life Sciences and Support Services industries. As of fiscal year 2025, the company is mainly focused on managing statutory obligations, litigation, and strategic restructuring following the divestment of its major operating subsidiaries. This divestment has resulted in a significant reduction in the company's operational scale. There is no information available regarding its founders, key management, headquarters, geographic presence, subsidiaries, or stock exchange listings.
This page is a live market overview for TAKE LIMITED (TAKE) on the NSE. As a listed security, TAKE LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for TAKE before placing trades on tick2trade.
As of the latest feed, TAKE last traded at ₹15.9 on NSE, up ₹0.06 (0.38%) from the previous close of ₹15.84. Today's session range is ₹15.75 – ₹16.39, against a 52-week band of ₹10.09 – ₹50.14. Traded volume today stands at 2.72L shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for TAKE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether TAKE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for TAKE LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in TAKE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated TAKE option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 11 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and other business matters | 20 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 14 Feb 2026 |
| Intimation | Board Meeting Intimation for Board Meeting To Be Held On Wednesday 11Th February 2026 | 11 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 7 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 30 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.